Showing results (1171-1180 of 12,117) with videos related to

Sort By:
Pageof 1,212
Neuropharmacology|May 19, 2011
Lacosamide has protective disease modifying properties in experimental vincristine neuropathyChristian Geis, Bettina K Beyreuther, Thomas Stöhr, et al.
Neuropharmacology|February 1, 1990
Stereochemical effects of 11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptorA C Howlett, T M Champion, G H Wilken, et al.
Neuropharmacology|April 28, 2011
Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophreniaK G Phillips, M C Cotel, A P McCarthy, et al.
Neuropharmacology|April 28, 2011
Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeysRobert W Gould, H Donald Gage, Matthew L Banks, et al.
Neuropharmacology|September 1, 1990
Antinociceptive effect of intrathecally-administered desipramine and zimelidine in ratsA Lund, A Tjølsen, K Hole
Neuropharmacology|May 7, 2011
Methylphenidate and μ opioid receptor interactions: a pharmacological target for prevention of stimulant abuseJinmin Zhu, Thomas J Spencer, Lee-Yuan Liu-Chen, et al.
Neuropharmacology|April 30, 2011
A microdialysis study of the medial prefrontal cortex of adolescent and adult ratsAmanda M Staiti, Peter J Morgane, Janina R Galler, et al.
Neuropharmacology|May 3, 2011
Timing as a window on cognition in schizophreniaRyan D Ward, Christoph Kellendonk, Eric R Kandel, et al.
Neuropharmacology|May 3, 2011
New translational assays for preclinical modelling of cognition in schizophrenia: the touchscreen testing method for mice and ratsT J Bussey, A Holmes, L Lyon, et al.
Neuropharmacology|May 3, 2011
Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depressionMathieu Nollet, Philippe Gaillard, Frédéric Minier, et al.
Pageof 1,212